Whitehawk Therapeutics Inc
NASDAQ: WHWK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David J. Lennon
- Employees
- 40
- Headquarters
- Pacific Palisades, United States
- IPO year
- 2017
- Market cap
- $217.1M
- Website
- https://ir.whitehawktx.com
Loading WHWK…
Loading profile data…Frequently asked questions about WHWK
What does Whitehawk Therapeutics Inc (WHWK) do?
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
Where does WHWK trade?
Whitehawk Therapeutics Inc (WHWK) trades on the NASDAQ Global Market.
What sector is WHWK in?
Whitehawk Therapeutics Inc (WHWK) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Whitehawk Therapeutics Inc?
David J. Lennon is the chief executive officer of Whitehawk Therapeutics Inc (WHWK).
Where is Whitehawk Therapeutics Inc headquartered?
Whitehawk Therapeutics Inc is headquartered in United States.
Does WHWK pay a dividend?
Whitehawk Therapeutics Inc (WHWK) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WHWK go public?
Whitehawk Therapeutics Inc (WHWK) completed its initial public offering in 2017.